Baluarte, Antonio .

HRN: 00-65-10  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
LEVOFLOXACIN 500MG (TAB)
12/15/2022
12/21/2022
PO
750mg
OD
CAP MR COPD In AE
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: